title: Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases.
abstract: Cutaneous benign lymphoid hyperplasia is a B-cell pseudolymphoma of unknown origin. The most favored sites of involvement include the face. We report two cases involving the nose that showed complete and stable regression after a 2-month treatment course with thalidomide.
authors.affiliation: Department of Dermatology, Hôpital Henri Mondor, Créteil, France.
authors.forename: H
authors.initials: H
authors.lastname: Benchikhi
authors.forename: C
authors.initials: C
authors.lastname: Bodemer
authors.forename: S
authors.initials: S
authors.lastname: Fraitag
authors.forename: J
authors.initials: J
authors.lastname: Wechsler
authors.forename: M H
authors.initials: MH
authors.lastname: Delfau-Larue
authors.forename: N
authors.initials: N
authors.lastname: Gounod
authors.forename: Y
authors.initials: Y
authors.lastname: de Prost
authors.forename: J
authors.initials: J
authors.lastname: Revuz
authors.forename: M
authors.initials: M
authors.lastname: Bagot
mesh_terms: D000293:Adolescent; D000328:Adult; D001402:B-Lymphocytes; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005148:Facial Dermatoses / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D009666:Nose; D019310:Pseudolymphoma / Q000188:drug therapy* / Q000473:pathology; D013792:Thalidomide / Q000627:therapeutic use*
chemical_list: D003879:Dermatologic Agents; D013792:Thalidomide